Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB)

Historical Holders from Q3 2020 to Q4 2025

Type / Class
Equity / Common Stock $0.001 par value per share
Symbol
SLDB on Nasdaq
Shares outstanding
77,821,012
Price per share
$5.64
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
81,357,989
Holdings value
$501,971,248
% of all portfolios
0%
Share change
-912,669
Value change
-$1,773,265
Average buys %
+0%
Average sells %
-0%
Number of holders
122
Price from insider filings
$5.43
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PERCEPTIVE ADVISORS LLC 16% $43,800,272 11,934,679 Perceptive Advisors LLC 19 Feb 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% $43,346,504 7,997,510 RA Capital Management, L.P. 12 Aug 2025
Invus Global Management, LLC 9.6% +2.2% $27,216,371 +$13,457,391 7,415,905 +98% Raymond Debbane 31 Mar 2025
BlackRock, Inc. 6.1% $22,954,472 4,712,573 BlackRock, Inc. 30 Jun 2025
Adage Capital Management, L.P. 5.1% -39% $24,680,000 -$16,840,916 4,000,000 -41% Adage Capital Management, L.P. 30 Sep 2025
Vestal Point Capital, LP 2.3% $6,435,558 1,753,558 Vestal Point Capital, LP 31 Mar 2025
As of 30 Sep 2025, Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) has 122 institutional shareholders filing 13F forms. They hold 81,357,989 shares .

Top 25 institutional shareholders own 92% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
PERCEPTIVE ADVISORS LLC 15% 11,833,539 -0.61% 2.1% $73,012,936
Bain Capital Life Sciences Investors, LLC 10% 7,911,669 0% 3.2% $48,814,998
Siren, L.L.C. 9.5% 7,415,905 0% 1.8% $45,756,134
RA CAPITAL MANAGEMENT, L.P. 7.5% 5,811,423 +0% 0.44% $35,856,480
BlackRock, Inc. 6.1% 4,725,118 -4% 0% $29,153,978
ADAGE CAPITAL PARTNERS GP, L.L.C. 5.1% 4,000,000 -41% 0.04% $24,680,000
VANGUARD GROUP INC 4% 3,083,850 -8.4% 0% $19,027,355
Vestal Point Capital, LP 3.8% 2,975,000 +98% 0.83% $18,355,750
FMR LLC 3.7% 2,914,127 -8.3% 0% $17,980,164
CITADEL ADVISORS LLC 3.3% 2,592,697 +2.8% 0.01% $15,996,940
Redmile Group, LLC 2.4% 1,899,342 -0.87% 1.1% $11,718,940
Nantahala Capital Management, LLC 2.2% 1,699,258 -0.24% 0.65% $10,484,422
Alyeska Investment Group, L.P. 2.2% 1,682,805 +2.6% 0.03% $10,382,906
MPM BIOIMPACT LLC 2.1% 1,634,569 0% 1.7% $10,085,291
FRANKLIN RESOURCES INC 2.1% 1,599,232 +0% 0% $9,867,261
Point72 Asset Management, L.P. 1.7% 1,333,005 +5.3% 0.02% $8,224,641
GEODE CAPITAL MANAGEMENT, LLC 1.7% 1,287,243 -15% 0% $7,943,954
STATE STREET CORP 1.4% 1,093,299 +15% 0% $6,745,655
Finepoint Capital LP 1.2% 961,251 0% 1.1% $5,930,919
ARMISTICE CAPITAL, LLC 1.2% 936,000 +134% 0.18% $5,775,120
MILLENNIUM MANAGEMENT LLC 1.2% 909,701 -17% 0% $5,612,855
BANK OF AMERICA CORP /DE/ 1% 789,996 -4.2% 0% $4,874,275
Balyasny Asset Management L.P. 0.94% 732,608 +50% 0.01% $4,520,191
UBS Group AG 0.93% 724,145 -6.2% 0% $4,467,975
GOLDMAN SACHS GROUP INC 0.87% 676,627 +77% 0% $4,174,788

Institutional Holders of Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 824 $4,648 +$926 $5.64 2
2025 Q3 81,357,989 $501,971,248 -$1,773,265 $6.17 122
2025 Q2 82,208,819 $400,360,815 +$32,116,218 $4.87 110
2025 Q1 78,846,500 $291,701,746 +$157,692,840 $3.70 121
2024 Q4 36,331,707 $145,326,212 -$2,638,776 $4.00 86
2024 Q3 35,844,916 $249,839,838 -$25,277,188 $6.97 90
2024 Q2 37,594,933 $213,228,886 +$13,669,240 $5.67 78
2024 Q1 34,987,922 $465,886,559 +$255,393,890 $13.32 52
2023 Q4 16,633,699 $102,223,957 +$4,578,230 $6.14 38
2023 Q3 16,169,847 $40,746,223 -$462,509 $2.52 34
2023 Q2 16,340,241 $85,622,446 +$3,108,792 $5.24 34
2023 Q1 15,773,407 $74,764,734 +$2,205,404 $4.74 35
2022 Q4 15,014,401 $80,763,090 +$80,763,090 $5.38 30
2020 Q4 0 $0 -$623,259 0
2020 Q3 307,024 $623,259 +$623,259 $2.03 1